Report Detail
Global Rotavirus Vaccines Market Insights, Forecast to 2025
- RnM3521234 |
- 14 June, 2019 |
- Global |
- 116 Pages |
- QYResearch |
- Pharma & Healthcare
Rotavirus vaccine is a vaccine used to protect against rotavirus infections, which are the leading cause of severe diarrhea among young children. The vaccines prevent 15–34% of severe diarrhea in the developing world and 37–96% of severe diarrhea in the developed world. The vaccines decrease the risk of death among young children due to diarrhea. Immunizing babies decreases rates of disease among older people and those who have not been immunized.
The World Health Organization (WHO) recommends that rotavirus vaccine be included in national routine vaccinations programs, especially in areas where the disease is common. This should be done along with promoting breastfeeding, handwashing, clean water and good sanitation. It is given by mouth and requires two or three doses. It should be given starting around six weeks of age.
The vaccines are safe. This includes their use in people with HIV/AIDS. An earlier vaccine that is no longer used was linked to intussusception, but the current versions are not clearly linked. Due to a potential risk they are not recommended in babies who have had intussusception. The vaccines are made from weakened rotavirus.
The vaccine first became available in the United States in 2006. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between US$6.96 and $20.66 per dose as of 2014.In the United States it is more than US$200. As of 2013 there are two types of vaccine available globally, Rotarix and RotaTeq. Others are used in some countries.
The global Rotavirus Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Rotavirus Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of Rotavirus Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Rotavirus Vaccines in these regions.
This research report categorizes the global Rotavirus Vaccines market by top players/brands, region, type and end user. This report also studies the global Rotavirus Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Bharat Biotech
Merck & Co., Inc
GlaxoSmithKline plc
Lanzhou Institute of Biological
Bharat Biotech International Limited
Market size by Product
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market size by End User
Adult
Pediatric
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Rotavirus Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Rotavirus Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Rotavirus Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Rotavirus Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Rotavirus Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Rotavirus Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Rotavirus Vaccines Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Rotavirus Vaccines Market Size Growth Rate by Product
- 1.4.2 Rotarix
- 1.4.3 RotaTeq
- 1.4.4 Rotavac
- 1.4.5 Rotavin-M1
- 1.4.6 Lanzhou lamb
- 1.4.7 Others
- 1.5 Market by End User
- 1.5.1 Global Rotavirus Vaccines Market Size Growth Rate by End User
- 1.5.2 Adult
- 1.5.3 Pediatric
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Rotavirus Vaccines Market Size
- 2.1.1 Global Rotavirus Vaccines Revenue 2014-2025
- 2.1.2 Global Rotavirus Vaccines Sales 2014-2025
- 2.2 Rotavirus Vaccines Growth Rate by Regions
- 2.2.1 Global Rotavirus Vaccines Sales by Regions
- 2.2.2 Global Rotavirus Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Rotavirus Vaccines Sales by Manufacturers
- 3.1.1 Rotavirus Vaccines Sales by Manufacturers
- 3.1.2 Rotavirus Vaccines Sales Market Share by Manufacturers
- 3.1.3 Global Rotavirus Vaccines Market Concentration Ratio (CR5 and HHI)
- 3.2 Rotavirus Vaccines Revenue by Manufacturers
- 3.2.1 Rotavirus Vaccines Revenue by Manufacturers (2014-2019)
- 3.2.2 Rotavirus Vaccines Revenue Share by Manufacturers (2014-2019)
- 3.3 Rotavirus Vaccines Price by Manufacturers
- 3.4 Rotavirus Vaccines Manufacturing Base Distribution, Product Types
- 3.4.1 Rotavirus Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Rotavirus Vaccines Product Type
- 3.4.3 Date of International Manufacturers Enter into Rotavirus Vaccines Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Rotavirus Vaccines Sales by Product
- 4.2 Global Rotavirus Vaccines Revenue by Product
- 4.3 Rotavirus Vaccines Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Rotavirus Vaccines Breakdown Data by End User
6 North America
- 6.1 North America Rotavirus Vaccines by Countries
- 6.1.1 North America Rotavirus Vaccines Sales by Countries
- 6.1.2 North America Rotavirus Vaccines Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Rotavirus Vaccines by Product
- 6.3 North America Rotavirus Vaccines by End User
7 Europe
- 7.1 Europe Rotavirus Vaccines by Countries
- 7.1.1 Europe Rotavirus Vaccines Sales by Countries
- 7.1.2 Europe Rotavirus Vaccines Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Rotavirus Vaccines by Product
- 7.3 Europe Rotavirus Vaccines by End User
8 Asia Pacific
- 8.1 Asia Pacific Rotavirus Vaccines by Countries
- 8.1.1 Asia Pacific Rotavirus Vaccines Sales by Countries
- 8.1.2 Asia Pacific Rotavirus Vaccines Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Rotavirus Vaccines by Product
- 8.3 Asia Pacific Rotavirus Vaccines by End User
9 Central & South America
- 9.1 Central & South America Rotavirus Vaccines by Countries
- 9.1.1 Central & South America Rotavirus Vaccines Sales by Countries
- 9.1.2 Central & South America Rotavirus Vaccines Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Rotavirus Vaccines by Product
- 9.3 Central & South America Rotavirus Vaccines by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Rotavirus Vaccines by Countries
- 10.1.1 Middle East and Africa Rotavirus Vaccines Sales by Countries
- 10.1.2 Middle East and Africa Rotavirus Vaccines Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Rotavirus Vaccines by Product
- 10.3 Middle East and Africa Rotavirus Vaccines by End User
11 Company Profiles
- 11.1 Bharat Biotech
- 11.1.1 Bharat Biotech Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Bharat Biotech Rotavirus Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Bharat Biotech Rotavirus Vaccines Products Offered
- 11.1.5 Bharat Biotech Recent Development
- 11.2 Merck & Co., Inc
- 11.2.1 Merck & Co., Inc Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Merck & Co., Inc Rotavirus Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Merck & Co., Inc Rotavirus Vaccines Products Offered
- 11.2.5 Merck & Co., Inc Recent Development
- 11.3 GlaxoSmithKline plc
- 11.3.1 GlaxoSmithKline plc Company Details
- 11.3.2 Company Business Overview
- 11.3.3 GlaxoSmithKline plc Rotavirus Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 GlaxoSmithKline plc Rotavirus Vaccines Products Offered
- 11.3.5 GlaxoSmithKline plc Recent Development
- 11.4 Lanzhou Institute of Biological
- 11.4.1 Lanzhou Institute of Biological Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Lanzhou Institute of Biological Rotavirus Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Lanzhou Institute of Biological Rotavirus Vaccines Products Offered
- 11.4.5 Lanzhou Institute of Biological Recent Development
- 11.5 Bharat Biotech International Limited
- 11.5.1 Bharat Biotech International Limited Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Bharat Biotech International Limited Rotavirus Vaccines Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Bharat Biotech International Limited Rotavirus Vaccines Products Offered
- 11.5.5 Bharat Biotech International Limited Recent Development
12 Future Forecast
- 12.1 Rotavirus Vaccines Market Forecast by Regions
- 12.1.1 Global Rotavirus Vaccines Sales Forecast by Regions 2019-2025
- 12.1.2 Global Rotavirus Vaccines Revenue Forecast by Regions 2019-2025
- 12.2 Rotavirus Vaccines Market Forecast by Product
- 12.2.1 Global Rotavirus Vaccines Sales Forecast by Product 2019-2025
- 12.2.2 Global Rotavirus Vaccines Revenue Forecast by Product 2019-2025
- 12.3 Rotavirus Vaccines Market Forecast by End User
- 12.4 North America Rotavirus Vaccines Forecast
- 12.5 Europe Rotavirus Vaccines Forecast
- 12.6 Asia Pacific Rotavirus Vaccines Forecast
- 12.7 Central & South America Rotavirus Vaccines Forecast
- 12.8 Middle East and Africa Rotavirus Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Rotavirus Vaccines Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Rotavirus Vaccines. Industry analysis & Market Report on Rotavirus Vaccines is a syndicated market report, published as Global Rotavirus Vaccines Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Rotavirus Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
